Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more

Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more

By Sreeja Biswas

  • 27 Dec 2024
Premium
Supriya Lifescience MD Saloni Wagh on adding capacity, topline target and more
Dr Saloni Wagh, MD, Supriya Lifescience

Bulk-drugs maker Supriya Lifescience Ltd, which was founded in 1987 and operates in therapeutic segments such as ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.
Advertisement

Related Articles

PE-backed Indira IVF and listed MosChip strike M&A deals

Healthcare

PE-backed Indira IVF and listed MosChip strike M&A deals

Premium
PAG eyes exit from healthcare portfolio firm, hires banker

Healthcare

PAG eyes exit from healthcare portfolio firm, hires banker

Pro
Aakash Healthcare nears deal to bring in PE investor

Healthcare

Aakash Healthcare nears deal to bring in PE investor

Pro
Motilal Oswal Alts gets an exit from decade-old bet with below-par returns

Healthcare

Motilal Oswal Alts gets an exit from decade-old bet with below-par returns

Premium
KKR-controlled Healthcare Global looks to expand footprint, weighs M&A

Healthcare

KKR-controlled Healthcare Global looks to expand footprint, weighs M&A

Everstone to invest $270 mn in drugmaker Apothecon

Healthcare

Everstone to invest $270 mn in drugmaker Apothecon

Premium
Quadria Capital plans partial exit from three-year-old healthcare bet

Healthcare

Quadria Capital plans partial exit from three-year-old healthcare bet

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW